Estudio en fase III, multicéntrico, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de JNJ-77242113 para el tratamiento de pacientes con psoriasis en placa de gravedad al menos moderada que afecte a zonas especiales o a una superficie corporal más pequeña.

Datos básicos

Protocolo:
77242113PSO3003
EUDRACT:
2023-505122-34
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2023
Año de finalización:
2024
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

JANSSEN CILAG INTERNATIONAL NV

Resultados del Ensayo Clínico


[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Couselo-Rodríguez C; (...); Flórez Á

Article. 10.1016/j.ad.2023.07.028. 2024

  • Open Access.

[[Translated article]]Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M; (...); Carrascosa-Carrillo, J M

Article. 10.1016/j.ad.2024.01.019. 2024

  • Open Access.

[Translated article] Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2024.03.015. 2024

  • Open Access.

A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties.

Orts-Arroyo, Marta; (...); Martinez-Lillo, Jose

Article. 10.3390/ijms25042112. 2024

  • Open Access.

Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.

Pérez-Alenda S; (...); Núñez-Cortés R

Article. 10.1111/hae.14988. 2024

  • Open Access.

Cutaneous sarcoidosis after platelet-rich plasma injections and permanent eyebrow make-up.

Torregrosa DM; (...); Estrada RB

Case Reports. 10.1016/j.ad.2023.06.023. 2024

  • Open Access.

Chikungunya fever with a positive tourniquet test: a novel description.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1093/ced/llae089. 2024


Dermatologic consultations for patients hospitalized in non-dermatologic wards: results of a 384-patient cross-sectional study from a tertiary referral hospital.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.11.021. 2023


Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

Daudén E; (...); Llamas-Velasco M

Article. 10.1111/ijd.16915. 2024

  • Open Access.

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Article. 10.1111/ijd.17030. 2024

  • Open Access.

Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ajd.14151. 2023


Erythema Elevatum Diutinum.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.10.042. 2024

  • Open Access.

Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.03.013. 2024

  • Open Access.

Identification of c.104T>G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad344. 2023


'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1007/s15010-024-02214-z. 2024


Melanoma and LEOPARD Syndrome: Understanding the Role of PTPN11 Mutations in Melanomagenesis.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.2340/actadv.v104.14720. 2024

  • Open Access.

Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ijd.16940. 2024


Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

Munoz-Aceituno, E.; (...); de la Fuente, H.

Article. 10.1111/jdv.19782. 2023


Podoconiosis.

Mansilla-Polo, Miguel, Lopez-Leon, Paula Teresa, Botella-Estrada, Rafael

Article. 10.1001/jamadermatol.2023.4143. 2023


Raccoon eyes as a diagnostic key for suspected amyloidosis

Mansilla-Polo, Miguel, Botella-Estrada, Rafael

Editorial Material. 10.1093/rap/rkad105. 2023

  • Open Access.

Reactive arthritis.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2023.08.017. 2023


Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series.

Martin-Torregrosa, Daniel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17022. 2024


Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M.; (...); Carrascosa-Carrillo, J. M.

Article. 10.1016/j.ad.2023.10.016. 2023

  • Open Access.

Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.

Lluch-Galcera, Juan Jose; (...); Garcia-Doval, Ignacio

Article. 10.1093/bjd/ljad382. 2023


Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features.

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.3390/jcm12247643. 2023

  • Open Access.

Single Digital Metastasis of Rectal Adenocarcinoma

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1097/DAD.0000000000002529. 2023

  • Open Access.

Skin lesions in a lung transplant recipient

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2023.09.005. 2024

  • Open Access.

Skin lesions in a lung transplant recipient.

Mansilla-Polo M; (...); Botella-Estrada R

Case Reports. 10.1016/j.eimce.2023.09.005. 2024

  • Open Access.

Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.

Lasheras-Pérez MA; (...); Rodriguez-Serna M

Article. 10.1111/ijd.16926. 2024


Tattoo-Associated Common Wart.

Mansilla-Polo, M, Llavador-Ros, M, Botella-Estrada, R

Article. 10.1016/j.ad.2023.04.037. 2023


Campos de Estudio

Compartir